Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency
- PMID: 12456880
- PMCID: PMC138598
- DOI: 10.1073/pnas.252630899
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency
Abstract
Human cytomegalovirus (HCMV) resides latently in hematopoietic cells of the bone marrow. Although viral genomes can be found in CD14+ monocytes and CD34+ progenitor cells, the primary reservoir for latent cytomegalovirus is unknown. We analyzed human hematopoietic subpopulations infected in vitro with a recombinant virus that expresses a green fluorescent protein marker gene. Although many hematopoietic cell subsets were infected in vitro, CD14+ monocytes and various CD34+ subpopulations were infected with the greatest efficiency. We have developed an in vitro system in which to study HCMV infection and latency in CD34+ cells cultured with irradiated stromal cells. Marker gene expression was substantially reduced by 4 days postinfection, and infectious virus was not made during the culture period. However, viral DNA sequences were maintained in infected CD34+ cells for >20 days in culture, and, importantly, virus replication could be reactivated by coculture with human fibroblasts. Using an HCMV gene array, we examined HCMV gene expression in CD34+ cells. The pattern of viral gene expression was distinct from that observed during productive or nonproductive infections. Some of these expressed viral genes may function in latency and are targets for further analysis. Altered gene expression in hematopoietic progenitors may be indicative of the nature and outcome of HCMV infection.
Figures
Similar articles
-
Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations.Blood. 2004 Aug 1;104(3):687-95. doi: 10.1182/blood-2003-12-4344. Epub 2004 Apr 13. Blood. 2004. PMID: 15090458
-
Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency.Blood. 1997 Sep 15;90(6):2482-91. Blood. 1997. PMID: 9310501
-
Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.J Virol. 2017 Feb 14;91(5):e01206-16. doi: 10.1128/JVI.01206-16. Print 2017 Mar 1. J Virol. 2017. PMID: 27974567 Free PMC article.
-
Human cytomegalovirus infection of human hematopoietic progenitor cells.Leuk Lymphoma. 1999 Mar;33(1-2):1-13. doi: 10.3109/10428199909093720. Leuk Lymphoma. 1999. PMID: 10194116 Review.
-
Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors.Scand J Infect Dis Suppl. 1995;99:63-7. Scand J Infect Dis Suppl. 1995. PMID: 8668945 Review.
Cited by
-
BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9575-80. doi: 10.1073/pnas.1207496109. Epub 2012 May 29. Proc Natl Acad Sci U S A. 2012. PMID: 22645331 Free PMC article.
-
Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.J Virol. 2018 Oct 12;92(21):e00880-18. doi: 10.1128/JVI.00880-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30089702 Free PMC article.
-
Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.J Virol. 2010 Jun;84(11):5594-604. doi: 10.1128/JVI.00348-10. Epub 2010 Mar 24. J Virol. 2010. PMID: 20335255 Free PMC article.
-
The Transcriptome of Latent Human Cytomegalovirus.J Virol. 2019 May 15;93(11):e00047-19. doi: 10.1128/JVI.00047-19. Print 2019 Jun 1. J Virol. 2019. PMID: 30867313 Free PMC article. Review.
-
Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.PLoS Pathog. 2011 Oct;7(10):e1002295. doi: 10.1371/journal.ppat.1002295. Epub 2011 Oct 6. PLoS Pathog. 2011. PMID: 21998590 Free PMC article.
References
-
- Britt W. J. & Alford, C. A. (1996) in Fields Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott–Raven, Philadelphia), Vol. 2, pp. 2493–2524.
-
- Sinzger C., Grefte, A., Plachter, B., Gouw, A. S., The, T. H. & Jahn, G. (1995) J. Gen. Virol. 76, 741-750. - PubMed
-
- Schrier R. D., Nelson, J. A. & Oldstone, M. B. (1985) Science 230, 1048-1051. - PubMed
-
- Boeckh M., Hoy, C. & Torok-Storb, B. (1998) Clin. Infect. Dis. 26, 209-210. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
